BioVectra DCL, a division of Diagnostic Chemicals Limited, officially opened its new 33,500 square foot manufacturing facility in Charlottetown today. Located at the Charlottetown Airport Business Park, the new state-of-the-art facility was constructed by BioVectra DCL to meet the demand for worldwide pharmaceutical goods and services.
"It's great to see the provincial economy diversifying into exciting new sectors that create employment opportunities to keep our talented young people at home," said the Honourable Pat Binns, Premier of Prince Edward Island. "BioVectra DCL has been an important cornerstone in Prince Edward Island's expanding life sciences community. With the success Diagnostic Chemicals Limited has achieved over the last 30 years, there is no doubt BioVectra DCL will continue to thrive in the PEI business environment."
"BioVectra is a shining example of entrepreneurship and innovation. It is proof positive of what can be achieved through hard work and dedication," said Shawn Murphy, Member of Parliament for Hillsborough on behalf of the Honourable Gerry Byrne, Minister of State for the Atlantic Canada Opportunities Agency. "We're very pleased to be continuing our relationship with one of PEI's leading companies through ACOA's Business Development Program to assist in the construction of this tremendous facility."
Company founder and chairman Regis Duffy commented, "With this new facility, BioVectra DCL joins a select group of manufacturers able to fully participate in the marketplace for the manufacturing of Active Pharmaceutical Ingredients (API's). With these enhanced manufacturing capabilities and new capacity, we are now in a position to more fully serve the biopharmaceutical industry worldwide. Already, we have seen significant levels of interest and demand from both new and existing customers who are eager to access BioVectra DCL's expanded capabilities."
The opening of the new BioVectra DCL facility will initially create 10 new jobs with up to 30 new positions established by the end of the first full year of operations.
BioVectra DCL currently develops and manufactures a range of specialty and fine chemicals, advanced intermediates, enzymes and biomolecules. The company also provides custom synthesis and manufacturing services for the pharmaceutical, biotechnology and nutraceutical industries, with several major multinational companies among its customers.
Diagnostic Chemicals Limited and BioVectra DCL, with their US and Mexican subsidiaries, are headquartered in Charlottetown, PEI and are privately held. Diagnostic Chemicals Limited has been listed as one of Canada's Top 100 Employers since 1991, with approximately 90 professionals employed in the BioVectra DCL division. For more information about BioVectra DCL, please visit the company's website at www.biovectra.com.